Home/Filings/4/0001493152-21-032035
4//SEC Filing

Morris Gabriel S 4

Accession 0001493152-21-032035

CIK 0001873835other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:15 PM ET

Size

17.6 KB

Accession

0001493152-21-032035

Insider Transaction Report

Form 4
Period: 2021-12-20
Morris Gabriel S
DirectorCFO
Transactions
  • Conversion

    Common Stock

    2021-12-20$0.85/sh+74,116$62,99974,116 total
  • Conversion

    Convertible Note

    2021-12-200 total
    Exercise: $0.85Common stock (74,116 underlying)
  • Conversion

    Convertible Note

    2021-12-200 total(indirect: See footnote)
    Exercise: $0.85Common stock (123,527 underlying)
  • Conversion

    Common Stock

    2021-12-20$0.85/sh+123,527$104,998123,527 total(indirect: See footnote)
  • Conversion

    Common Stock

    2021-12-20$0.85/sh+123,176$104,700246,703 total(indirect: See footnote)
  • Conversion

    Convertible Note

    2021-12-200 total(indirect: See footnote)
    Exercise: $0.85Common stock (123,176 underlying)
  • Purchase

    Common Stock

    2021-12-20$5.00/sh+2,000$10,00076,116 total
Footnotes (4)
  • [F1]On March 18, 2021, the Registrant issued the Reporting Person a note in the amount of $60,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.
  • [F2]On March 18, 2021, the Registrant issued Alwaysraise LLC a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.
  • [F3]Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity.
  • [F4]On April 2, 2021, the Registrant issued Alwaysraise a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.

Documents

1 file

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1
  • filerCIK 0001889967

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:15 PM ET
Size
17.6 KB